Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;40(3):310-325.
doi: 10.1002/humu.23691. Epub 2018 Dec 8.

Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation

Affiliations

Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation

Meng Han et al. Hum Mutat. 2019 Mar.

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Here, we show the identification and functional characterization of one AF-associated mutation p.Arg399Cys in lamin A/C. Co-immunoprecipitation and GST pull-down assays demonstrate that lamin A/C interacts with NUP155, which is a nucleoporin and causes AF when mutated. Lamin A/C mutation p.Arg399Cys impairs the interaction between lamin A/C and NUP155, and increases extractability of NUP155 from the nuclear envelope (NE). Mutation p.Arg399Cys leads to aggregation of lamin A/C in the nucleus, although it does not impair the integrity of NE upon cellular stress. Mutation p.Arg399Cys inhibits the export of HSP70 mRNA and the nuclear import of HSP70 protein. Electrophysiological studies show that mutation p.Arg399Cys decreases the peak cardiac sodium current by decreasing the cell surface expression level of cardiac sodium channel Nav 1.5, but does not affect IKr potassium current. In conclusion, our results indicate that lamin A/C mutation p.Arg399Cys weakens the interaction between nuclear lamina (lamin A/C) and the nuclear pore complex (NUP155), leading to the development of AF. The findings provide a novel molecular mechanism for the pathogenesis of AF.

Keywords: LMNA; NUP155; SCN5A/Nav1.5; atrial fibrillation (AF); mutation.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

The authors declare that they have no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Identification of the p.Arg399Cys mutation in LMNA associated with AF. (a) DNA sequences of LMNA from an affected patient and a normal individual. A heterozygous missense mutation (c.1195C>T, p.Arg399Cys) was identified in the affected patient. (b) Multiple amino acid sequence alignment of lamin A proteins. The p.Arg399Cys mutation occurs at an arginine (R) residue that is evolutionarily conserved. (c) Schematic structure of the LMNA gene and lamin A protein. The p.Arg399Cys mutation was found in exon 7. NLS, nuclear localization signal
FIGURE 2
FIGURE 2
Mutation p.Arg399Cys affects the localization of lamin A. (a) Immunofluorescence analysis of EGFP-tagged WT or p.Arg399Cys lamin A expressed in HL-1 cells. WT lamin A was correctly localized to the nuclear periphery in the majority of the cells, while p.Arg399Cys showed a higher frequency of a “foci” phenotype. Data are presented as mean ± SEM, *P < 0.05. (b) Analysis of lamin B1 localization in cells expressing WT or mutant lamin A with p.Arg399Cys. EGFP-tagged WT or p.Arg399Cys mutant LMNA plasmid was transfected into HL-1 cells. The p.Arg399Cys mutation did not disturb the distribution of endogenous lamin B1 on the nuclear rim. Scale bar: 10 μm
FIGURE 3
FIGURE 3
Lamin A interacts with NUP155. (a) Co-immunoprecipitation (Co-IP) assays. HeLa cells were transiently transfected with a FLAG-LMNA-WT plasmid, and cell lysates were immunoprecipitated with anti-FLAG antibody, followed by immunoblotting analysis (IB) with an anti-NUP155 antibody. Emerin was used as a positive control, and normal IgG were used as negative control. (b) Reciprocal co-immunoprecipitation assays. HeLa cells were transiently transfected with a FLAG-LMNA-WT plasmid. Cell lysates were immunoprecipitated with anti-NUP155 antibody and analyzed by immunoblotting analysis (IB) with an anti-FLAG antibody. NUP205 was used as a positive control, and normal IgG were used as negative control. (c) Bacterial expression of recombinant GST-lamin A. Protein expression was induced by 0 or 0.5 mM IPTG, the recombinant protein was analyzed by SDS-PAGE and Coomassie brilliant blue staining. The result indicated that the N-terminal or the C-terminal truncated lamin A protein was expressed. The arrow indicated the estimated size of the truncated fusion proteins. Asterisk indicated the location of the full length fusion proteins. (d) GST pull-down assays. The cell lysates extracted from HeLa cells were incubated with a purified GST fusion N-terminal or C-terminal truncated lamin A protein or negative control GST. GST-LMNA-C-WT, but not GST-LMNA-N-WT or control GST, pulled down the endogenous NUP155. Coomassie brilliant blue staining showed the amount of protein. The arrow indicated the estimated size of fusion proteins
FIGURE 4
FIGURE 4
LMNA mutation p.Arg399Cys weakens binding of lamin A to NUP155, and increased extractability of NUP155 from NE. (a) GST pull-down assays. Nuclear extracts from HeLa cells were incubated with GST-LMNA-C-WT or GST-LMNA-C- p.Arg399Cys. Coomassie brilliant blue staining showed the approximately equal amount of WT and mutant fusion proteins. The interaction between endogenous NUP155 and mutant lamin A with p.Arg399Cys was significantly reduced by 42% compared with WT lamin A. The arrow indicated the estimated size of fusion proteins. Data are presented as mean ± SEM, *P < 0.05. (b) Mutant lamin A with p.Arg399Cys did not affect the expression level of endogenous NUP155 protein. EGFP-LMNA-WT or EGFP-LMNA-R399C was transferred into HeLa cells, and cell lysates were analyzed by Western blotting with an anti-NUP155 antibody or a control anti-α-tubulin antibody. (c) Mutant lamin A with p.Arg399Cys did not affect the NUP155 localization at NE (nuclear envelope). EGFP-LMNA-WT or EGFP-LMNA-R399C was transferred into HeLa cells, and the cytoplasmic and NE extracts were analyzed by Western blotting with antibodies for NUP155 and lamin B1. Cyto: cytoplasm; NE: nuclear envelope. (d) Mutant lamin A with p.Arg399Cys increased the extractability of NUP155 from NE. EGFP-LMNA-WT or EGFP-LMNA-R399C was transferred to HeLa cells, and the insoluble NE fraction was prepared by treatment with TrionX-100. The extracted NE (eNE) was further re-extracted with increasing concentrations of NaCl, and analyzed by Western blotting with an anti- NUP155 antibody or an anti-lamin B1 as a positive control. S, supernatant; P, precipitate. The relative NUP155 protein level at the Y-axis was expressed as either S/S+P or P/S+P. Data are presented as mean ± SEM, *P < 0.05
FIGURE 5
FIGURE 5
LMNA mutation p.Arg399Cys reduces the export of HSP70 mRNA, and nuclear import of HSP70 protein. (a) Analysis of nuclear import of HSP70 protein in HL-1 cells transiently transfected using a EGFP-LMNA-WT or EGFP-LMNA-R399C LMNA expression plasmid for 48 hr. Data are presented as mean ± SEM, *P < 0.05, **P < 0.01; n, number of images analyzed as indicated. (b) Analysis of the nuclear export of HSP70 mRNA in HL-1 cells. After heat shock, total RNA from nuclear or cytoplasmic fractions was isolated and reverse-transcribed with random primers. Quantitative real time RT-PCR analysis was used to estimate the levels of HSP70 mRNA in the cytoplasm and nucleus. LMNA mutation p.Arg399Cys inhibits HSP70 mRNA export into the cytoplasm. Data are presented as mean ± SEM, *P < 0.05
FIGURE 6
FIGURE 6
LMNA mutation p.Arg399Cys decreases cardiac sodium current density in HEK293/Nav1.5 cells. (a) Representative whole-cell sodium currents recorded from HEK/Nav1.5 cells transfected with a EGFP-LMNA-WT or p.Arg399Cys mutant expression plasmid. (b) The relationship of average current densities (current normalized to cell capacitance) and voltages. (c) Peak sodium current densities at –25 mV. Data are presented as mean ± SEM, *P < 0.05. (d) Steady-state activation curve. (e) Steady-state inactivation curve
FIGURE 7
FIGURE 7
LMNA mutation p.Arg399Cys decreases the cell surface expression level of Nav1.5 without affecting the expression of total Nav1.5 in HEK293/Nav1.5 cells. (a) Western blotting analysis of total Nav1.5 protein in HEK293/Nav1.5 cells transiently transfected with a EGFP-LMNA-WT or EGFP-LMNA-R399C LMNA expression plasmid for 48 hr. Data are presented as mean ± SEM. ns, not significant. (b) Western blotting analysis of cell surface expression levels of Nav1.5 in HEK293/Nav1.5 cells. Data are presented as mean ± SEM, *P < 0.05

Similar articles

Cited by

References

    1. Adhikari AS, Sridhar Rao K, Rangaraj N, Parnaik VK, & Mohan Rao C (2004). Heat stress-induced localization of small heat shock proteins in mouse myoblasts: Intranuclear lamin A/C speckles as target for alphaB-crystallin and Hsp25. Experimental Cell Research, 299(2), 393–403. 10.1016/j.yexcr.2004.05.032 - DOI - PubMed
    1. Afzal AR, Mandal K, Nyamweya S, Foteinos G, Poloniecki J, Camm AJ, … Xu Q (2008). Association of Met439Thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum HSP70 protein levels. Cardiology, 110(1), 45–52. 10.1159/000109406 - DOI - PubMed
    1. Allende M, Molina E, Guruceaga E, Tamayo I, Gonzalez-Porras JR, Gonzalez-Lopez TJ, … Hermida J (2016). Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk. Cardiovascular Research, 110(3), 309–318. 10.1093/cvr/cvw049 - DOI - PubMed
    1. Andalib A, Brugada R, & Nattel S (2008).Atrial fibrillation: Evidence for genetically determined disease. Current Opinion in Cardiology, 23(3), 176–183. 10.1097/HCO.0b013e3282fa7142 - DOI - PubMed
    1. Arimura T, Helbling-Leclerc A, Massart C, Varnous S, Niel F, Lacene E, … Bonne G (2005). Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Human Molecular Genetics, 14(1), 155–169. 10.1093/hmg/ddi017 - DOI - PubMed

Publication types

MeSH terms